Peptide library / Pinealon

Pinealon

Pinealon is the synthetic tripeptide Glu-Asp-Arg, also described by the short code EDR.

Peptide & blend guide

The short version

Why people discuss it
Discussed for memory, mental clarity and sleep/circadian support. Community interest does not establish benefit or a suitable treatment.
What it is
Pinealon is the synthetic tripeptide Glu-Asp-Arg, also described by the short code EDR.
Biggest caution
Mechanistic, animal or small product-specific reports do not establish cognitive or longevity benefit. Sequence identity, formulation, comparative evidence and long-term human safety remain uncertain.
Stack context
Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.

Dose and frequency reference

Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.

Sources report different amounts or schedules; the reference below is a named example, not a consensus.

Subcutaneous injection

Community reference · Not clinical guidance
Amount
1–2 mg
Frequency
Once daily
Duration / phase
10–20 days

One publisher’s example, not a consensus midpoint. Older sources span 100–300 mcg/day to 10–20 mg/day. The 10–20-day course agrees more consistently than the amount. Intranasal use is a separate route. Reference only; this does not establish safety, effectiveness or individual suitability.

Community source · reviewed 2026-09-27
Compare reported schedules

Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.

Evidence & sources · Community source profile

AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.

Back to the peptide library